{"id":"placebo-for-varenicline","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo is an inert substance used as a control in clinical trials to measure the effect of an active drug (in this case, varenicline) against baseline or non-specific therapeutic effects. Any observed benefit from placebo is attributed to psychological factors, natural disease progression, or regression to the mean rather than direct molecular action.","oneSentence":"A placebo contains no active pharmaceutical ingredient and produces no direct pharmacological effect.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:01:06.970Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control arm in clinical trials for smoking cessation (varenicline comparator)"}]},"trialDetails":[{"nctId":"NCT06582888","phase":"EARLY_PHASE1","title":"Advancing VR-based Attentional Bias as a Biomarker for Tobacco Use Disorder","status":"RECRUITING","sponsor":"University of California, San Diego","startDate":"2024-11-19","conditions":"Nicotine Addiction, Craving","enrollment":200},{"nctId":"NCT02162849","phase":"PHASE4","title":"Reward Sensitivity and Pharmacotherapy for Smoking Cessation","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2015-12-14","conditions":"Tobacco Use Cessation","enrollment":204},{"nctId":"NCT02271919","phase":"PHASE4","title":"Varenicline and Combined NRT for Smoking Cessation","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2015-05-14","conditions":"Cigarette Smoker, Tobacco Use Disorder","enrollment":631},{"nctId":"NCT06883162","phase":"PHASE3","title":"Cannabis-Tobacco Co-Use Treatment Study","status":"RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2025-05-06","conditions":"Tobacco Use Disorder, Tobacco Use Cessation, Cannabis Use","enrollment":200},{"nctId":"NCT05703672","phase":"PHASE3","title":"Switching to E-cigarettes in Smokers Not Interested in Quitting","status":"RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2023-07-17","conditions":"Smoking Reduction","enrollment":500},{"nctId":"NCT03630614","phase":"PHASE3","title":"Randomized Trial of Electronic Cigarettes With or Without Nicotine in Smoking Cessation.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2018-10-17","conditions":"Smoking Cessation, Smoking, Cigarette, Electronic Cigarette","enrollment":650},{"nctId":"NCT07040566","phase":"PHASE2","title":"A Trial of Varenicline for E-cigarette Cessation","status":"RECRUITING","sponsor":"Yale University","startDate":"2025-10-14","conditions":"E-cigarette Use, Vaping, Nicotine Dependence","enrollment":326},{"nctId":"NCT00943618","phase":"PHASE3","title":"Combining Varenicline and Bupropion for Smoking Cessation","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2010-05-17","conditions":"Smoking Cessation","enrollment":641},{"nctId":"NCT05367492","phase":"PHASE4","title":"Varenicline for Nicotine Vaping Cessation in Adolescents","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2022-06-22","conditions":"Vaping, Nicotine Dependence","enrollment":261},{"nctId":"NCT06679374","phase":"PHASE2","title":"Reducing Falls With Varenicline in Hypocholinergic Parkinson Disease","status":"RECRUITING","sponsor":"Vikas Kotagal","startDate":"2025-04-09","conditions":"Parkinson Disease","enrollment":102},{"nctId":"NCT02460900","phase":"PHASE3","title":"Optimizing Smoking Cessation for People With HIV/AIDS Who Smoke","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2016-07","conditions":"Smoking, HIV","enrollment":184},{"nctId":"NCT05541497","phase":"PHASE2","title":"Varenicline for Treatment of E-cigarette Dependence","status":"COMPLETED","sponsor":"Yale University","startDate":"2022-11-04","conditions":"Smoking Cessation","enrollment":40},{"nctId":"NCT03365362","phase":"PHASE4","title":"A Trial of Directly Observed and Long-term Varenicline","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2018-10-25","conditions":"Tobacco Use Disorder, Opioid-use Disorder","enrollment":243},{"nctId":"NCT05294263","phase":"PHASE2","title":"Varenicline for the Treatment of Cannabis and Tobacco Use Disorders in Veterans","status":"WITHDRAWN","sponsor":"VA Office of Research and Development","startDate":"2023-04-17","conditions":"Tobacco Use Disorder, Cannabis Use Disorder","enrollment":""},{"nctId":"NCT04167306","phase":"PHASE2","title":"Varenicline and Bupropion for Alcohol Use Disorder","status":"COMPLETED","sponsor":"Vastra Gotaland Region","startDate":"2019-03-04","conditions":"Alcohol Use Disorder, Alcoholism, Alcohol Dependence","enrollment":388},{"nctId":"NCT01511614","phase":"NA","title":"Nicotine Withdrawal Symptoms and Smoking Relapse","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2013-05-20","conditions":"Nicotine Dependence","enrollment":112},{"nctId":"NCT03235505","phase":"PHASE4","title":"Efficacy and Safety of E-cigarettes for Smoking Cessation in Middle-aged Heavy Smokers","status":"COMPLETED","sponsor":"University of Oulu","startDate":"2018-08-01","conditions":"Smoking Cessation, Electronic Cigarette","enrollment":450},{"nctId":"NCT03059563","phase":"PHASE1","title":"Dopamine D2/D3 Receptor Upregulation by Varenicline in Methamphetamine Users","status":"TERMINATED","sponsor":"University of California, Los Angeles","startDate":"2018-01-11","conditions":"Dopamine D2/3 Receptor Availability, Cognitive Function, Methamphetamine Abuse","enrollment":62},{"nctId":"NCT04602494","phase":"PHASE4","title":"Varenicline For Nicotine Vaping Cessation In Non Smoker Vaper Adolescents","status":"TERMINATED","sponsor":"Massachusetts General Hospital","startDate":"2020-12-18","conditions":"Vaping, Nicotine Dependence","enrollment":5},{"nctId":"NCT00727103","phase":"PHASE4","title":"Varenicline Treatment in Alcohol and Nicotine Dependent Patients With Schizophrenia","status":"COMPLETED","sponsor":"State University of New York - Upstate Medical University","startDate":"2008-07","conditions":"Schizophrenia, Schizoaffective Disorder, Alcohol Dependence","enrollment":10},{"nctId":"NCT03980561","phase":"PHASE2","title":"UH3 Varenicline for Cannabis Use Disorder","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2020-01-31","conditions":"Cannabis Use Disorder","enrollment":174},{"nctId":"NCT01413516","phase":"PHASE2","title":"Varenicline In-Patient Study","status":"COMPLETED","sponsor":"Stanford University","startDate":"2011-08","conditions":"Smoking Cessation","enrollment":17},{"nctId":"NCT04249882","phase":"PHASE2","title":"A Novel Human Lab Model for Screening AUD Medications","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2020-01-28","conditions":"Alcohol Use Disorder","enrollment":53},{"nctId":"NCT03497299","phase":"PHASE2","title":"Combining rTMS With Varenicline to Prevent Smoking Lapse in Schizophrenia","status":"WITHDRAWN","sponsor":"Centre for Addiction and Mental Health","startDate":"2018-07-01","conditions":"Tobacco Use Disorder, Schizophrenia, Cognitive Functioning","enrollment":""},{"nctId":"NCT05082974","phase":"PHASE3","title":"Investigator Initiated Study to Assess the Efficacy of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease Following Laser-assisted in Situ Keratomileusis (LASIK)","status":"COMPLETED","sponsor":"Vance Thompson Vision ND","startDate":"2021-10-20","conditions":"Dry Eye Disease","enrollment":40},{"nctId":"NCT05378945","phase":"PHASE3","title":"Clinical Trial to Evaluate the Efficacy and Safety of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease","status":"COMPLETED","sponsor":"Corxel Pharmaceuticals","startDate":"2022-07-22","conditions":"Dry Eye Disease","enrollment":340},{"nctId":"NCT03176784","phase":"PHASE4","title":"UW Quitting Using Intensive Treatment Study (QUITS)","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2017-11-11","conditions":"Tobacco Dependence","enrollment":1251},{"nctId":"NCT02723162","phase":"PHASE2","title":"Translational Neuropsychopharmacology Research of Nicotine Addiction","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2016-05-04","conditions":"Nicotine Dependence, Cigarettes","enrollment":67},{"nctId":"NCT02856581","phase":"PHASE3","title":"Management of Tobacco Treatment Intervention in Reducing Surgical Complications in Patients With Newly Diagnosed Lung Cancer Who Smoke Cigarettes","status":"TERMINATED","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2017-09-29","conditions":"Lung Carcinoma","enrollment":23},{"nctId":"NCT03507127","phase":"PHASE2","title":"Targeted Pharmacological and Behavioral Treatments for Smoking in Schizophrenia Study 1","status":"TERMINATED","sponsor":"Brown University","startDate":"2018-05-01","conditions":"Tobacco Dependence","enrollment":5},{"nctId":"NCT00554840","phase":"PHASE2","title":"Comparison of Varenicline and Placebo for Smoking Cessation in Schizophrenia","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2007-11","conditions":"Cigarette Smoking, Schizophrenia","enrollment":16},{"nctId":"NCT05136924","phase":"PHASE2","title":"IIT Assessing OC-01Nasal Spray on Symptoms of DED Following CXL","status":"UNKNOWN","sponsor":"Vance Thompson Vision - MT","startDate":"2021-12-01","conditions":"Dry Eye Disease","enrollment":20},{"nctId":"NCT02634281","phase":"PHASE4","title":"Extended (6-Week) Varenicline Preloading: Does it Facilitate Smoking Reduction and Cessation?","status":"COMPLETED","sponsor":"Shaare Zedek Medical Center","startDate":"2016-02","conditions":"Smoking Cessation","enrollment":242},{"nctId":"NCT02859142","phase":"PHASE4","title":"Varenicline Augmentation of Patch Outcomes in Heavy Drinkers' Smoking Cessation","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2018-03-29","conditions":"Smoking Cessation, Alcohol Drinking","enrollment":122},{"nctId":"NCT05045508","phase":"PHASE3","title":"Investigator Initiated Study to Assess the Efficacy of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease Following Photorefractive Keratectomy (PRK)","status":"UNKNOWN","sponsor":"Brandon Baartman","startDate":"2021-08-30","conditions":"Dry Eye","enrollment":60},{"nctId":"NCT02501265","phase":"PHASE2","title":"Adaptive Pharmacotherapy for Smoking Cessation","status":"COMPLETED","sponsor":"Duke University","startDate":"2017-06-06","conditions":"Nicotine Dependence","enrollment":188},{"nctId":"NCT00860028","phase":"PHASE2","title":"Varenicline for Smoking Cessation in Heavy Drinking Smokers","status":"COMPLETED","sponsor":"Yale University","startDate":"2008-10","conditions":"Nicotine Dependence, Smoking, Heavy Drinking","enrollment":30},{"nctId":"NCT02378714","phase":"PHASE4","title":"Behavioral Activation and Varenicline for Smoking Cessation in Depressed Smokers","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2015-07-24","conditions":"Nicotine Dependence, Major Depressive Disorder","enrollment":300},{"nctId":"NCT02412631","phase":"PHASE2, PHASE3","title":"Addressing Post Cessation Weight Gain","status":"TERMINATED","sponsor":"Mayo Clinic","startDate":"2016-06-15","conditions":"Obesity, Smoking Cessation","enrollment":84},{"nctId":"NCT01027754","phase":"PHASE4","title":"Smoking Cessation Treatment for Methadone Maintenance Patients","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2009-08","conditions":"Smoking Cessation, Substance-Related Disorders","enrollment":112},{"nctId":"NCT00507728","phase":"PHASE2, PHASE3","title":"Pharmacogenetics, Emotional Reactivity and Smoking","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2005-12-08","conditions":"Tobacco Use Disorder, Smoking Cessation","enrollment":646},{"nctId":"NCT02575183","phase":"PHASE4","title":"Varenicline (Chantix) Treatment for Waterpipe Smoking Cessation","status":"COMPLETED","sponsor":"American University of Beirut Medical Center","startDate":"2016-08-31","conditions":"Nicotine Dependence","enrollment":152},{"nctId":"NCT04035603","phase":"PHASE2","title":"Multimodal Cue Exposure Therapy for Smoking Cessation","status":"WITHDRAWN","sponsor":"Boston University Charles River Campus","startDate":"2020-10-01","conditions":"Smoking Cessation","enrollment":""},{"nctId":"NCT04403399","phase":"PHASE2","title":"Crossover Target Engagement Study of Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease (Project #3 - Experiment 3 [UdallP3E3])","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2017-06-29","conditions":"Parkinson's Disease","enrollment":34},{"nctId":"NCT02797587","phase":"PHASE2, PHASE3","title":"Studying Partial-agonists for Ethanol and Tobacco Elimination in Russians With HIV (St PETER HIV)","status":"COMPLETED","sponsor":"Boston Medical Center","startDate":"2017-07-19","conditions":"HIV Infection, Alcohol Use, Smoking","enrollment":400},{"nctId":"NCT00749658","phase":"PHASE2, PHASE3","title":"Human Laboratory Study of Varenicline and Bupropion for Nicotine Dependence","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2008-11","conditions":"Nicotine Dependence, Nicotine Withdrawal","enrollment":121},{"nctId":"NCT02351167","phase":"PHASE4","title":"Genetically Informed Smoking Cessation Trial","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2015-05-20","conditions":"Smoking Cessation","enrollment":822},{"nctId":"NCT01151813","phase":"PHASE2","title":"Human Behavioral Pharmacology Laboratory (HBPL) Study of Varenicline's Impact on Cocaine and Alcohol Craving","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2010-07","conditions":"Alcohol Dependence, Cocaine Dependence","enrollment":15},{"nctId":"NCT02360631","phase":"PHASE4","title":"Advancing Tobacco Use Treatment for African American Smokers","status":"COMPLETED","sponsor":"Lisa Sanderson Cox, PhD","startDate":"2015-07-29","conditions":"Smoking Cessation","enrollment":500},{"nctId":"NCT01509547","phase":"PHASE3","title":"Varenicline for Adolescent Smoking Cessation","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2012-08","conditions":"Nicotine Dependence","enrollment":157},{"nctId":"NCT02193256","phase":"EARLY_PHASE1","title":"Varenicline + Prazosin for Heavy Drinking Smokers","status":"COMPLETED","sponsor":"Yale University","startDate":"2014-07","conditions":"Cigarette Smoking, Alcohol Use Disorders","enrollment":5},{"nctId":"NCT02551692","phase":"NA","title":"Effects of Smoking Environments on Craving and Smoking (CameraCue2.0)","status":"COMPLETED","sponsor":"Duke University","startDate":"2016-01","conditions":"Cigarette Smoking","enrollment":125},{"nctId":"NCT02892110","phase":"PHASE2","title":"Varenicline Treatment for Cannabis Use Disorder","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2017-02-13","conditions":"Substance Use Disorder","enrollment":72},{"nctId":"NCT03035708","phase":"PHASE1, PHASE2","title":"Human Laboratory Study of Varenicline for Alcohol Use Disorder","status":"COMPLETED","sponsor":"National Institute on Alcohol Abuse and Alcoholism (NIAAA)","startDate":"2017-05-01","conditions":"Alcohol Use Disorder","enrollment":47},{"nctId":"NCT01710137","phase":"PHASE3","title":"Varenicline for Nicotine Dependence Among Those With HIV/AIDS","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2012-10","conditions":"Nicotine Dependence","enrollment":179},{"nctId":"NCT01680887","phase":"PHASE2","title":"A Phase II Trial of Varenicline for the Treatment of Cocaine Dependence","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2012-08","conditions":"Cocaine Dependence","enrollment":156},{"nctId":"NCT01756885","phase":"PHASE3","title":"Extended Varenicline Treatment for Smoking Among Cancer Patients","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2013-01","conditions":"Nicotine Dependence","enrollment":207},{"nctId":"NCT00794573","phase":"PHASE3","title":"Evaluation of Varenicline (Champix) in Smoking Cessation for Patients Post-Acute Coronary Syndrome (EVITA) Trial","status":"COMPLETED","sponsor":"Mark Eisenberg","startDate":"2009-09","conditions":"Acute Coronary Syndrome","enrollment":302},{"nctId":"NCT02473562","phase":"PHASE4","title":"Varenicline Treatment for Excessive Daytime Sleepiness in Parkinson's Disease","status":"TERMINATED","sponsor":"Amsterdam UMC, location VUmc","startDate":"2013-05","conditions":"Parkinson's Disease","enrollment":22},{"nctId":"NCT00756275","phase":"NA","title":"Varenicline and Motivational Advice for Smokers With Substance Use Disorders","status":"COMPLETED","sponsor":"Brown University","startDate":"2009-01","conditions":"Smoking Cessation, Nicotine Dependence","enrollment":158},{"nctId":"NCT01312909","phase":"PHASE4","title":"Smoking Cessation Study In Healthy Adolescent Smokers","status":"COMPLETED","sponsor":"Pfizer","startDate":"2011-04","conditions":"Smoking Cessation","enrollment":312},{"nctId":"NCT00790569","phase":"NA","title":"Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking","status":"COMPLETED","sponsor":"Butler Hospital","startDate":"2008-09","conditions":"Bladder Cancer, Cervical Cancer, Esophageal Cancer","enrollment":315},{"nctId":"NCT02488889","phase":"PHASE4","title":"Effects of Varenicline in Heavy Drinking Smokers","status":"WITHDRAWN","sponsor":"University of California, Los Angeles","startDate":"2015-08","conditions":"Cigarette Smoking, Alcohol Consumption","enrollment":""},{"nctId":"NCT00664755","phase":"PHASE2","title":"Menstrual Cycle Effects on Smoking Cessation and Cue Reactivity","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2007-07","conditions":"Nicotine Dependence","enrollment":140},{"nctId":"NCT00773422","phase":"PHASE2","title":"The Effect of Naltrexone and Varenicline on Alcohol-Mediated Smoking Lapse","status":"COMPLETED","sponsor":"Yale University","startDate":"2008-01","conditions":"Smoking","enrollment":30},{"nctId":"NCT00713479","phase":"PHASE1","title":"An Assessment of the Safety of Varenicline in Methamphetamine-dependent Volunteers","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2008-07","conditions":"Methamphetamine Addiction, Crystal Meth Addiction, Amphetamine Addiction","enrollment":8},{"nctId":"NCT01639560","phase":"PHASE4","title":"Varenicline for Light Smokers","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2013-01","conditions":"Smoking","enrollment":93},{"nctId":"NCT00580853","phase":"PHASE2","title":"The Effect of Varenicline (Chantix) and Bupropion (Zyban) on Smoking Lapse Behavior","status":"COMPLETED","sponsor":"Yale University","startDate":"2007-04","conditions":"Smoking Lapse Behavior","enrollment":62},{"nctId":"NCT00580645","phase":"PHASE2","title":"Do Treatments for Smoking Cessation Affect Alcohol Drinking?","status":"COMPLETED","sponsor":"Yale University","startDate":"2007-04","conditions":"Alcohol Drinking","enrollment":60},{"nctId":"NCT01347112","phase":"PHASE2, PHASE3","title":"Varenicline Treatment for Active Alcoholic Smokers","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2011-06","conditions":"Smoking, Tobacco Dependence, Alcohol Dependence","enrollment":33},{"nctId":"NCT01685996","phase":"PHASE1, PHASE2","title":"Zonisamide Augmentation of Varenicline Treatment for Smoking Cessation","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2012-09","conditions":"Nicotine Dependence","enrollment":74},{"nctId":"NCT01365819","phase":"PHASE2","title":"Varenicline for Methamphetamine Dependence","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2012-02","conditions":"Methamphetamine Dependence, Substance Abuse, Methamphetamine Abuse","enrollment":52},{"nctId":"NCT00621777","phase":"PHASE4","title":"A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2008-02","conditions":"Schizophrenia, Schizoaffective Disorder, Bipolar Disorder","enrollment":247},{"nctId":"NCT02106637","phase":"NA","title":"Early In-hospital Initiation of Pharmacotherapy for Smoking Cessation, Patients After ACS","status":"UNKNOWN","sponsor":"Sheba Medical Center","startDate":"2016-10","conditions":"Acute Coronary Syndrome, Smoking Cessation","enrollment":300},{"nctId":"NCT01010204","phase":"PHASE4","title":"Varenicline Treatment for Smoking Cessation in Patients With Bipolar Disorder","status":"COMPLETED","sponsor":"K.N. Roy Chengappa","startDate":"2010-01","conditions":"Smoking Cessation, Bipolar Disorder","enrollment":60},{"nctId":"NCT00802919","phase":"PHASE4","title":"Varenicline for Cognitive Deficits and Cigarette Smoking in Schizophrenia - Efficacy and Predictors","status":"COMPLETED","sponsor":"Nathan Kline Institute for Psychiatric Research","startDate":"2008-09","conditions":"Schizophrenia, Cigarette Smoking","enrollment":93},{"nctId":"NCT01406223","phase":"PHASE3","title":"Mechanistic Evaluations of Pre-Cessation Therapies for Smoking Cessation","status":"COMPLETED","sponsor":"Duke University","startDate":"2011-07","conditions":"Nicotine Dependence","enrollment":282},{"nctId":"NCT01524627","phase":"PHASE2","title":"Effects of Varenicline on Smoking Reminders","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2011-12","conditions":"Nicotine Dependence","enrollment":124},{"nctId":"NCT01531049","phase":"PHASE2, PHASE3","title":"Smoking Habits and Smoking Cessation in Young Adults","status":"COMPLETED","sponsor":"Tuula Toljamo","startDate":"2012-05","conditions":"Smoking Cessation, Smoking, Habits","enrollment":300},{"nctId":"NCT00835900","phase":"PHASE2","title":"An Alternative Dosing Schedule of Varenicline for Smoking Cessation","status":"COMPLETED","sponsor":"Roswell Park Cancer Institute","startDate":"2009-03","conditions":"Smoking Cessation","enrollment":60},{"nctId":"NCT00282984","phase":"PHASE3","title":"Efficacy and Safety of Varenicline in Smokers With Cardiovascular Disease Who Wish to Quit Smoking","status":"COMPLETED","sponsor":"Pfizer","startDate":"2006-02","conditions":"Smoking Cessation","enrollment":714},{"nctId":"NCT00455650","phase":"NA","title":"Study of the Effects of Mecamylamine and Varenicline in Schizophrenia","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2007-03","conditions":"Cognition in Schizophrenia","enrollment":89},{"nctId":"NCT01850953","phase":"PHASE4","title":"Effects of Varenicline on Smoking Lapse in Smokers With and Without Schizophrenia","status":"COMPLETED","sponsor":"Centre for Addiction and Mental Health","startDate":"2013-06","conditions":"Craving, Smoking, Schizophrenia","enrollment":28},{"nctId":"NCT01574703","phase":"PHASE4","title":"Study To Evaluate Cardiac Assessments Following Different Treatments Of Smoking Cessation Medications In Subjects With And Without Psychiatric Disorders.","status":"COMPLETED","sponsor":"Pfizer","startDate":"2012-05","conditions":"Smoking Cessation","enrollment":4595},{"nctId":"NCT01093365","phase":"PHASE2","title":"Effect of Varenicline on Cognitive Function in Cigarette Smokers With Schizophrenia","status":"COMPLETED","sponsor":"Centre for Addiction and Mental Health","startDate":"2010-03","conditions":"Schizophrenia, Schizoaffective Disorder","enrollment":58},{"nctId":"NCT00695500","phase":"PHASE1, PHASE2","title":"Varenicline to Reduce Alcohol Consumption in Heavy Drinkers","status":"COMPLETED","sponsor":"Vijay Ramchandani, Ph.D.","startDate":"2008-06","conditions":"Alcohol Drinking","enrollment":50},{"nctId":"NCT01456936","phase":"PHASE4","title":"Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders","status":"COMPLETED","sponsor":"Pfizer","startDate":"2011-11","conditions":"Smoking Cessation","enrollment":8144},{"nctId":"NCT01772641","phase":"PHASE4","title":"A Smoking Intervention Study Using Scheduled Gradual Reduction With Varenicline to Help With Cessation","status":"TERMINATED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2012-12","conditions":"Nicotine Addiction","enrollment":32},{"nctId":"NCT01314001","phase":"PHASE3","title":"Pharmacogenetics of Nicotine Addiction Treatment","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2010-12","conditions":"Nicotine Addiction","enrollment":1246},{"nctId":"NCT01532232","phase":"","title":"Tobacco Dependence in Breast Cancer Patients Trial of Varenicline (Chantix)","status":"TERMINATED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2012-02","conditions":"Breast Cancer, Tobacco Dependence","enrollment":7},{"nctId":"NCT01387425","phase":"NA","title":"Efficacy And Safety Of Smoking Cessation With Varenicline Tartrate In Diabetic Smokers: (DIASMOKE)","status":"COMPLETED","sponsor":"Universita degli Studi di Catania","startDate":"2011-06","conditions":"Smoking Cessation, Diabetes","enrollment":300},{"nctId":"NCT00691483","phase":"PHASE4","title":"Randomized Study Comparing the Efficacy and Safety of Varenicline Tartrate to Placebo in Smoking Cessation When Subjects Are Allowed to Set Their Own Quit Date","status":"COMPLETED","sponsor":"Pfizer","startDate":"2008-09","conditions":"Smoking Cessation","enrollment":659},{"nctId":"NCT00828113","phase":"PHASE4","title":"Long-term Varenicline Treatment for Smoking Cessation","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2009-01","conditions":"Smoking","enrollment":101},{"nctId":"NCT00150241","phase":"PHASE2","title":"A Seven-Week Dose-Ranging Study of CP-526,555 Compared With Placebo and Zyban for Smoking Cessation","status":"COMPLETED","sponsor":"Pfizer","startDate":"2000-02","conditions":"Smoking Cessation","enrollment":625},{"nctId":"NCT00873535","phase":"NA","title":"Effect of Varenicline on Reactivity to Smoking and Drinking Cues","status":"COMPLETED","sponsor":"Centre for Addiction and Mental Health","startDate":"2008-10","conditions":"Tobacco Dependence, Alcohol Dependence","enrollment":48},{"nctId":"NCT01098305","phase":"PHASE2","title":"Efficacy of Varenicline for Smokeless Tobacco Use in India","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2011-04","conditions":"Tobacco Use Disorder","enrollment":237},{"nctId":"NCT00717093","phase":"PHASE4","title":"Study Evaluating The Efficacy Of Varenicline In Cessation Of Oral Smokeless Tobacco Use","status":"COMPLETED","sponsor":"Pfizer","startDate":"2008-08","conditions":"Tobacco Use Cessation","enrollment":432},{"nctId":"NCT00781755","phase":"PHASE4","title":"Treating Schizophrenic Smokers: Effects on Craving, Cues and Withdrawal","status":"WITHDRAWN","sponsor":"VA Boston Healthcare System","startDate":"","conditions":"Tobacco Use Disorder","enrollment":""},{"nctId":"NCT00705523","phase":"PHASE2","title":"Varenicline (Chantix™) for the Treatment of Alcohol Dependence","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2008-06","conditions":"Alcoholism","enrollment":40},{"nctId":"NCT00741884","phase":"PHASE2","title":"A Study to Evaluate the Safety and Efficacy of Three Doses of a Controlled Release Formulation of Varenicline for Smoking Cessation","status":"WITHDRAWN","sponsor":"Pfizer","startDate":"2010-08","conditions":"Smoking Cessation","enrollment":""}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":511,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["placebo for Champix(R) / Chantix(R)","Placebo"],"phase":"marketed","status":"active","brandName":"Placebo for varenicline","genericName":"Placebo for varenicline","companyName":"Nathan Kline Institute for Psychiatric Research","companyId":"nathan-kline-institute-for-psychiatric-research","modality":"Small molecule","firstApprovalDate":"","aiSummary":"A placebo contains no active pharmaceutical ingredient and produces no direct pharmacological effect. Used for Control arm in clinical trials for smoking cessation (varenicline comparator).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}